Syncona Ltd (CHIX:SYNCl)
£ 1.108 -0.015 (-1.34%) Market Cap: 716.93 Mil Enterprise Value: 716.91 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 40/100

Half Year 2024 Syncona Ltd Earnings Call Transcript

Nov 16, 2023 / 09:00AM GMT
Release Date Price: £1.29 (-4.59%)
Christopher J. Hollowood
Syncona Investment Management Limited - CEO

My name is Chris Hollowood, CEO of Syncona, and I welcome you to our Interim Presentation. Over the last 6 months, we've been focused on executing on strategy against the backdrop of a very challenging market. We reported a small decline in NAV principally because of the write off of the Gyroscope milestone after Novartis' decision to discontinue GT005. We talked about at the full year a rigorous capital allocation policy, which we think is essential to navigate this market. The macroeconomic environment continues to be very challenging for biotech companies both in terms of the cost of the capital, but also the access to that capital. That brings financing risk clearly, but also brings opportunity and we're looking at both. Proactive management of the portfolio is key. We are active managers so our skill set really comes to the fore.

We know clinical data is value even in this market and that is where we're focused and that can be seen because 80% of the capital we've deployed in the first 6 months of this financial year has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot